Running title
Fractionated rituximab to prevent tumour lysis syndrome
NCT trial number: NCT05840289
Key-words: tumour lysis syndrome, aggressive B lymphoma, rituximab
Funding : This research received no external funding.
Conflicts of Interest : The authors declare no conflicts of interest.